Meng, L., Li, H., Ji, Y., Yu, P., Wang, Z., Cao, L., . . . Zhu, Z. Efficacy, safety, and biomarker analysis of TACE combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: A real-world study. Springer.
Chicago Style (17th ed.) CitationMeng, Lingzhan, et al. Efficacy, Safety, and Biomarker Analysis of TACE Combined with Lenvatinib Plus Sintilimab in Unresectable Hepatocellular Carcinoma: A Real-world Study. Springer.
MLA (9th ed.) CitationMeng, Lingzhan, et al. Efficacy, Safety, and Biomarker Analysis of TACE Combined with Lenvatinib Plus Sintilimab in Unresectable Hepatocellular Carcinoma: A Real-world Study. Springer.
Warning: These citations may not always be 100% accurate.